BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37778281)

  • 1. Increased adherence to ACOG diagnostic guidelines for HDP following a workshop in Bolivia, a LMIC.
    Toledo-Jaldin L; Lazo-Vega L; Grau L; Lawrence I; Larrea-Alvarado A; Mizutani R; Rocabado S; Vasan V; Sammel M; Julian CG; Moore LG
    Pregnancy Hypertens; 2023 Dec; 34():19-26. PubMed ID: 37778281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG and local diagnostic criteria for hypertensive disorders of pregnancy (HDP) in La Paz-El Alto, Bolivia: A retrospective case-control study.
    Lazo-Vega L; Toledo-Jaldin L; Badner A; Barriga-Vera JL; Castro-Monrroy M; Euser AG; Larrea-Alvarado A; Lawrence I; Mérida C; Mizutani R; Pérez Y; Rocabado S; Vargas M; Vasan V; Julian CG; Moore LG
    Lancet Reg Health Am; 2022 May; 9():. PubMed ID: 35719175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative Analysis of Diagnostic Value of 24-h Proteinuria for Preeclampsia.
    Zhuang X; Chen YY; Zhou Q; Lin JH
    Chin Med J (Engl); 2015 Nov; 128(22):2998-3002. PubMed ID: 26608977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of hypertensive disorders of pregnancy in Africa: A systematic review and meta-analysis.
    Noubiap JJ; Bigna JJ; Nyaga UF; Jingi AM; Kaze AD; Nansseu JR; Fokom Domgue J
    J Clin Hypertens (Greenwich); 2019 Apr; 21(4):479-488. PubMed ID: 30848083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hypertensive disorders during pregnancy in France (2010-2018): The Nationwide CONCEPTION Study.
    Olié V; Moutengou E; Grave C; Deneux-Tharaux C; Regnault N; Kretz S; Gabet A; Mounier-Vehier C; Tsatsaris V; Plu-Bureau G; Blacher J
    J Clin Hypertens (Greenwich); 2021 Jul; 23(7):1344-1353. PubMed ID: 34042277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.
    de Sonnaville CMW; Hukkelhoven CW; Vlemmix F; Groen H; Schutte JM; Mol BW; van Pampus MG
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):58-67. PubMed ID: 31486156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and maternal prognosis of hypertension disorders of pregnancy in French Guiana.
    Mhiri R; Mvogo A; Kamga A; Yassinguezo S; Fagla H; Dotou D; Kallel H
    Pregnancy Hypertens; 2020 Apr; 20():96-101. PubMed ID: 32224440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case-control study.
    Chen Y; Chen Y; Wang X; Chu X; Ning W; Gu L; Li L; Xie Z; Wen C
    J Transl Med; 2021 Mar; 19(1):94. PubMed ID: 33653375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and perinatal outcomes of hypertensive disorders in pregnancy: Insights from the National Hospital of Obstetrics and Gynecology in Vietnam.
    Thi Huyen Anh N; Manh Thang N; Thanh Huong T
    PLoS One; 2024; 19(1):e0297302. PubMed ID: 38295097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensive disorders of pregnancy and risks of adverse pregnancy outcomes: a retrospective cohort study of 2368 patients.
    Li X; Zhang W; Lin J; Liu H; Yang Z; Teng Y; Huang J; Peng Q; Lin X; Zhang J; Xie L; Xie Y; Li Y; Luo J; Duan W; Chen J; Duan S
    J Hum Hypertens; 2021 Jan; 35(1):65-73. PubMed ID: 32066825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the clinical impact of the revised ISSHP and ACOG definitions on preeclampsia.
    Bouter AR; Duvekot JJ
    Pregnancy Hypertens; 2020 Jan; 19():206-211. PubMed ID: 31836469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis.
    van Oostwaard MF; Langenveld J; Schuit E; Papatsonis DN; Brown MA; Byaruhanga RN; Bhattacharya S; Campbell DM; Chappell LC; Chiaffarino F; Crippa I; Facchinetti F; Ferrazzani S; Ferrazzi E; Figueiró-Filho EA; Gaugler-Senden IP; Haavaldsen C; Lykke JA; Mbah AK; Oliveira VM; Poston L; Redman CW; Salim R; Thilaganathan B; Vergani P; Zhang J; Steegers EA; Mol BW; Ganzevoort W
    Am J Obstet Gynecol; 2015 May; 212(5):624.e1-17. PubMed ID: 25582098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of hypertensive disorders during pregnancy on the perinatal outcome of different chorionic twins.
    Che R; Pei J; Chen H; Dong L; Wu Y; Hua X
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7146-7152. PubMed ID: 34180344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACC-AHA Diagnostic Criteria for Hypertension in Pregnancy Identifies Patients at Intermediate Risk of Adverse Outcomes.
    Darwin KC; Federspiel JJ; Schuh BL; Baschat AA; Vaught AJ
    Am J Perinatol; 2021 Aug; 38(S 01):e249-e255. PubMed ID: 32446257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal near-miss and death among women with hypertensive disorders in pregnancy: a secondary analysis of the Nigeria Near-miss and Maternal Death Survey.
    Adamu AN; Okusanya BO; Tukur J; Ashimi AO; Oguntayo OA; Tunau KA; Ekele BA; Oladapo OT
    BJOG; 2019 Jun; 126 Suppl 3():12-18. PubMed ID: 30270518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes.
    Leaños-Miranda A; Méndez-Aguilar F; Ramírez-Valenzuela KL; Serrano-Rodríguez M; Berumen-Lechuga G; Molina-Pérez CJ; Isordia-Salas I; Campos-Galicia I
    Medicine (Baltimore); 2017 Jan; 96(4):e6005. PubMed ID: 28121958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening.
    Khan N; Andrade W; De Castro H; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):50-57. PubMed ID: 31503372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New immune horizons in therapeutics and diagnostic approaches to Preeclampsia.
    Mukherjee I; Singh S; Karmakar A; Kashyap N; Mridha AR; Sharma JB; Luthra K; Sharma RS; Biswas S; Dhar R; Karmakar S
    Am J Reprod Immunol; 2023 Feb; 89(2):e13670. PubMed ID: 36565013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of pre-eclampsia using two revised classifications in the Finnish Pre-eclampsia Consortium (FINNPEC) cohort.
    Kallela J; Jääskeläinen T; Kortelainen E; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Laivuori H
    BMC Pregnancy Childbirth; 2016 Aug; 16():221. PubMed ID: 27520381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.